Promising biotech firm names new president, CEO

E. Russell McAllister succeeds Kevin Sill as the leader of Intezyne.

  • By Business Observer Staff
  • | 6:00 a.m. March 19, 2018
  • | 0 Free Articles Remaining!
  • Tampa Bay-Lakeland
  • Share

TAMPA — E. Russell McAllister is the new president and CEO of Intezyne, a clinical-stage biopharmaceutical company headquartered at the USF Tampa Bay Technology Incubator.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • February 7, 2026
Tampa airport unveils final design for new $1.5B airside terminal
  • February 7, 2026
Report: NY, Idaho among feeder states for Sarasota, Manatee growth
  • February 6, 2026
Southwest Florida homebuilder dies at 91
  • February 6, 2026
California dental insurer cutting Tampa jobs

Sponsored Content